About SVM

Click a title below to jump to that section.

Mission & Vision

Mission Statement

The mission of the Society for Vascular Medicine is to promote and advance the discipline of vascular medicine and the care of patients with vascular disease by:

  • Establishing standards for post-graduate training and stimulating the formation of vascular medicine training programs.
  • Developing educational activities including continuing medical education programs for trainees and health care providers.
  • Fostering research in vascular medicine and biology.
  • Promoting interdisciplinary clinical excellence in the diagnosis and treatment of vascular disease through the creation of care standards and by engaging in quality improvement activities.
  • Serving an advisory role to educational institutions, government agencies, and other health care organizations.

SVM’s Vision

SVM: Promoting and advancing the discipline of vascular medicine and the care of patients with vascular disease

The Society for Vascular Medicine is a professional organization that was founded in 1989 to foster a broad mission. The goals of the Society are to improve the integration of vascular biological advances into medical practice, and to maintain high standards of clinical vascular medicine.

The Society is distinguished by its emphasis on clinical approaches to vascular disorders. Optimal vascular care is best accomplished by the collegial interaction of a community of vascular professionals, including individuals with expertise in vascular medicine, cardiovascular medicine, interventional cardiology, vascular surgery, interventional radiology, vascular nursing, vascular technology, and other disciplines.

The Society recognizes the importance of individuals with diverse backgrounds in achieving ideal standards of research and clinical practice. The Society encourages cultural competence and DEI awareness at all levels in its mission to promote vascular health across various demographics inclusive of racial/ethnic, gender identity/sexual orientation, ability status, religious and socioeconomic background.


In 1989, 14 individuals met and formed the Society for Vascular Medicine and Biology. Dr. Jess Young was the first president. By 2000, SVMB had 255 members, astounding because there were not yet boards in vascular medicine.
View the SVM Past Presidents >>.

Shortly after the founding of SVMB, Drs. John Cooke and Victor Dzau wrote a powerful editorial in the Annals of International Medicine titled, “The time has come for vascular medicine.” In this editorial, they said,

“Vascular medicine is beginning to take form as a small but growing cadre of internists in this country who have acquired special expertise in treating vascular disease.” They noted that “these advances, although impressive, have lagged far behind the explosive growth in vascular biology… consequently, vascular disorders are being treated piecemeal by physicians from various backgrounds.”

While cardiology fellowship programs are supposed to prepare their fellows for cardiovascular boards, most are long on the cardio and short on the vascular. In the late 1980s and early 1990s, a larger number of cardiologists became interested in peripheral vascular diseases, especially as it related to interventional procedures for these patients.

The founding of the Society for Vascular Medicine and Biology in Anaheim, California on 19 March 1989. From left: Drs Alan Hirsch, Marvin Sachs, Philip (Jack) Osmundson, Jay Coffman (then President-Elect), Jess Young (then President), Mark Creager, Michael Weber, Victor Dzau, John (Jack) Spittel Jr, John Joyce, John P Cooke, Sheldon Sheps, James Sowers.

Courses abounded teaching others “the how to of peripheral intervention.” In the early years, many of the leaders in this area were very well trained in the technical aspects of endovascular therapy but less knowledgeable in the natural history, non-invasive evaluation and medical treatment of these disorders.

When Dr. R.L. Grye, president of the American College of Cardiology wrote in the Journal of the American College of Cardiology, a column titled “Role of the cardiologist in peripheral vascular disease,” SVM responded with a letter to the editor stating:

The time is long overdue to recognize the fact that vascular medicine is more than just interventional therapy, imaging or medical care of the vascular surgical patient. Without a thorough understand of the etiology, pathophysiology and natural history of the disease, as well as a knowledge of medical, surgical and interventional technologies, care for the patient with peripheral vascular disease will be less than optimal. The notion that a cardiologist who is trained in invasive cardiac technology can apply these same procedures to the peripheral vasculature is a misconception.

Highlights and accomplishments

  • In 1997, SVMB hosted the Royal Society of Angiology for the first transatlantic vascular medicine meeting in Boston, Mass. Individuals from the UK and the United States participated in this meeting and initiated discussions on how the two societies could work together to expand vascular medicine.
  • In 1999, SVMB, the Royal Society of Angiology and the Swedish Society for Vascular Medicine met in Edinburg, Scotland. These three societies held the 3rd Transatlantic Vascular Medicine Symposium: The Pharmacotherapy of Peripheral Arterial Disease: An Expanding Frontier for Vascular Therapies.
  • In 1999 and 2000, five societies participated in the Vascular Centers of Excellence Conference in Chicago. The SVMB, American College of Cardiology, the Society for Vascular Surgery, the International Society for Cardiovascular Surgery, and the Society for Vascular and Interventional Radiology put together a program to assist in the development of vascular centers and to search for solutions for the problems that often prevent vascular centers from being successful.
  • SVM has been involved in the education of vascular specialists and many primary care specialties.
  • Under the leadership of Dr. Alan Hirsch, SVM, with an unrestricted grant from Otsuka Pharmaceuticals, began an initiative — The PAD Primary Care Series — to educate primary care physicians. This series served as the most ambitious effort to date to create both public and physician awareness of the importance of peripheral arterial disease.
  • Under the leadership of Dr. Mark Creager, the SVM journal, Vascular Medicine, was indexed and has worldwide distribution. Dr. Heather Gornik assumed the leadership of the journal in 2014.
  • In 2005, SVM introduced the SVM Board Review Course, held in conjunction with the SVM Annual Scientific Sessions. The Board Review Course prepares physicians who are preparing for the Certification Exams offered by the American Board of Vascular Medicine. From 2011 to 2015, the SVM Board Review Course has been presented in conjunction with VIVA (Vascular InterVentional Advances) in Las Vegas. In 2016, SVM began to offer the Board Review Course independently.
  • In 2006, the Society joined the PAD Coalition, the first national PAD Awareness campaign in partnership with the National Heart, Lung, and Blood Institute. The PAD Coalition, an alliance of leading health organizations united together to raise public awareness about lower extremity PAD, developed an array of patient education resources available free for health care professionals and the general public.
  • In 2007, SVMB changed its name to the Society for Vascular Medicine.
  • In 2007, the Master of the Society for Vascular Medicine designation was established. The MSVM designation is conferred upon individuals who have provided extraordinary service to the Society. View the Master of the Society for Vascular Medicine page. >>
  • In 2008 the Jay D. Coffman Young Investigator Award was established in memory of Dr. Coffman. The award recognizes young investigator research during the Vascular Scientific Sessions. View the Jay D. Coffman Young Investigator Award page. >>
  • In 2010 the Jess R. Young Outstanding Vascular Medicine Educator Award was established. The award is conferred upon individuals who have made an exemplary contribution to the field of vascular medicine through the education of its practitioners. View the Jess R. Young Outstanding Vascular Medicine Educator Award page. >>
  • In 2017 the Allan T. Hirch Travel Award was established. SVM offers travel awards to promote the interest of younger vascular clinicians, practitioners, and vascular researchers to attend the Vascular Scientific Sessions. This is designed to facilitate participation for those without adequate financial resources to attend. View the ALAN T. HIRSCH, MD, TRAVEL AWARD page. >>
  • Elected in 2017, Dr. Heather Gornik became the first woman President of the Society.
  • In 2018 the Mark A. Creager Prize for Research Excellence was established. This annual award is given in honor of Dr. Mark A. Creager for his 19 years of excellence as Editor-in-Chief of Vascular Medicine and more than 28 years of service to the Society, including service as SVM President from 1993-1995. The Creager Prize recognizes the authors of the most meritorious original research paper published in Vascular Medicine and will be given annually. View the SVM Mark A. Creager Prize for Research Excellence page. >>
  • In 2018 SVM commissioned the first Vascular Medicine Comprehensive Practice and Salary benchmarking survey and report. View the Comprehensive Practice & Salary Survey page. >>
  • In 2020 under the leadership of Dr. Raghu Kolluri, SVM establied the Diversity, Equity, and Inclusion Taskforce. The taskforce advises on DEI matters as they apply to all Society functions, including membership, leadership, education, research, quality, clinical care and advocacy. The DEI taskforce ensures that every member of the vascular medicine community has full opportunity to thrive in our environment.

Past Presidents

Past SVM Presidents at the 30th SVM Annual Meeting

Back row, left to right: Jeffrey Olin, Thomas Rooke, Michael Jaff, William Hiatt, John R. (Jerry) Bartholomew, James B. Froehlich. Front row, left to right: Michael Bacharach, Heather Gornik, Mark Creager, Raghu Kolluri, Josh Beckman.

SVM 25th Annual Meeting

A quorum of our past, present, and future presidents at the 2014 SVM Scientific Sessions. From left: John R Bartholomew, Jim Froehlich, Joshua Beckman, J Michael Bacharach, John Cooke, Alan Hirsch, Jeffrey Olin, Thom Rooke, Mark Creager.

Raghu Kolluri, MD, MS, RVT, FSVM

Heather Gornik, MD, FSVM

John R. (Jerry) Bartholomew, MD, MSVM

James B. Froehlich, MD, MPH, MSVM

Joshua A. Beckman, MD, MSVM

Thom Rooke, MD, MSVM

J. Michael Bacharach, MD, MPH, MSVM

John P. Cooke, MD, MSVM

Michael R. Jaff, DO, MSVM

Jonathan L. Halperin, MD, MSVM

Jeffrey W. Olin, DO, MSVM

Alan T. Hirsch, MD, MSVM

William R. Hiatt, MD, MSVM

Mark A. Creager, MD, MSVM

Jay D. Coffman, MD, MSVM

Jess Young, MD, MSVM